FDA Approved: DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE — Original Application (Endo USA, Inc.)

View source ↗

Summary

The FDA approved Endo USA, Inc.'s original application for a generic doxylamine succinate and pyridoxine hydrochloride delayed-release tablet (10 mg/10 mg).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nausea and Vomiting in Pregnancy

Drugs mentioned

• Doxylamine succinate and pyridoxine hydrochloride, delayed-release tablets 10 mg/10 mg (Doxylamine succinate and pyridoxine hydrochloride)

Snippet

ORIG AP for DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE (DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE, DELAYED RELEASE TABLETS 10 MG/10 MG)